Elizabeth Holland, a senior partner in Goodwin's IP Litigation practice, is an experienced trial lawyer who focuses exclusively on patent infringement and related litigation. With over 30 years of experience, Ms. Holland has served as lead trial counsel in numerous patent infringement litigations, licensing disputes, arbitrations and IPR proceedings. Ms. Holland has also argued several Federal Circuit appeals. She has particular expertise in disputes between branded drug companies, Hatch-Waxman litigation on behalf of both branded and generic drug companies, and biosimilars litigation.

Ms. Holland is consistently ranked among the top lawyers in her field by publications such as Chambers GlobalChambers USA, IAM 1000 – The World's Leading Patent Practitioners, The Legal 500 U.S., Managing Intellectual Property, LMG Life Sciences and Euromoney, which have noted her “assured handling of even the most complex pharmaceuticals patent cases” and have described her as “exactly what you want in a first-chair lawyer; she is very skilled in the courtroom, very adept at managing multiple important cases, and well-liked by judges.” She has also been noted as being “exceptional on her feet in court;” getting “excellent results;” and “understanding clients’ business goals and litigating with those in mind.” Ms. Holland has twice been named “Hatch Waxman Litigator of the Year” by LMG Life Sciences and has been featured as a “Winning Litigator” by the National Law Journal.





Professional Experience

Ms. Holland has successfully represented companies such as Novartis, Teva, Actavis, Lupin, Sun, Ceva Sante, Enzymotec, Celltrion and Boston Scientific in patent litigation in district courts throughout the United States, at the International Trade Commission, in post-grant proceedings before the PTAB, and at the Federal Circuit. Ms. Holland has also coordinated worldwide patent litigation, and has particular experience with courts in the UK, Netherlands, France, Israel, India and Mexico.

Ms. Holland’s significant victories include:

  • Wins in S.D.N.Y. (after trial), Federal Circuit and U.S. Supreme Court in consolidated patent litigations concerning the drug Copaxone®.
  • Wins in D.N.J. (after trial) and Federal Circuit in patent litigation concerning the drug Atelvia®.
  • Win in D. Del. (after trial) in patent litigation concerning the drug Quillivant®.
  • Multiple wins in D. Del. and Federal Circuit (including motion for judgment under Rule 52(c) granted during trial) in patent litigation concerning the drug Uceris®.
  • Wins at PTAB in IPRs on patents on the drug Ravicti®.
  • Win in D.N.J. (defeated TRO and PI motions) in patent litigation concerning the drug Abilify®. Achieved subsequent favorable settlement.
  • Wins in S.D. Ind. (after trial) and Federal Circuit in patent litigation concerning the drug Gemzar®.
  • Win in D. Mass. (after trial) in patent litigation concerning the drug Relafen®. Achieved favorable settlement while on appeal.
  • Wins in D. Del. (on summary judgment) and Federal Circuit in patent litigation concerning coronary stents.
  • Wins in S.D.N.Y. (on summary judgment) and Federal Circuit in patent litigation concerning pertussis vaccines.
  • Win in D.N.J. in a false advertising case concerning x-ray contrast agents.

Ms. Holland has also achieved numerous favorable settlements on behalf of clients.

Prior to joining Goodwin in 2014, Ms. Holland was a partner at Kenyon & Kenyon in New York City, where she chaired its Diversity, Equity + Inclusion Committee and was the first woman to serve on its Management Committee. She previously practiced at Paul Weiss, where she litigated a wide variety of cases.


Ms. Holland was a 2021 recommended lawyer for Patent litigation: full coverage by The Legal 500. Benchmark Litigation recognizes Ms. Holland as a 2021 Litigation Star in New York for her work in Intellectual Property. Ms. Holland is currently recognized in WIPR Leaders 2021; as a leading lawyer by Chambers GlobalChambers USA; in the Gold Band in the IAM Patent 1000 – The World's Leading Patent Practitioners; as one of the Top 250 Women in Litigation by Benchmark Litigation; as one of the Top 50 Women in PTAB Trials by the PTAB Bar Association; as an IP Star by Managing Intellectual Property; in the top 10% of practitioners (of more than 5,000 lawyers) in Patexia IPR Intelligence Report; and in Life Sciences Expert Guide 2019. She is a past recipient of the Euromoney Women in Business Law Best in Life Sciences Award and is two-time winner of the LMG Life Sciences Hatch-Waxman Litigator of the Year Award. She has also been featured as a “Winning Litigator” in the National Law Journal and a “Trial Pro” in Law360.

In The News









J.D., 1988
Benjamin N. Cardozo School of Law
(magna cum laude)
B.S., Chemical Engineering, 1985
The Cooper Union



New York
U.S. Patent and Trademark Office (USPTO)


U.S. District Court for the Eastern District of New York
U.S. District Court for the Southern District of New York
U.S. Court of Appeals for the Federal Circuit
U.S. Supreme Court
Profile Image
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.


Search Other Lawyers
Recherche par Pratique